Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alkermes (ALKS – Research Report), Eledon Pharmaceuticals (ELDN – Research Report) and Legend ...

DUBLIN, March 1, 2018 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the appointment of James (Jim) Robinson as President and Chief Operating Officer, effective March 5, 2018.

The stocks we picked back then include Novocure (NASDAQ: NVCR), ACADIA (NASDAQ: ACAD), Alexion (NASDAQ: ALXN), and Alkermes (NASDAQ: ALKS). Alexion ($23 billion, -3% YTD) is a pharma company ...

Alkermes PLC (NASDAQ:ALKS) is a fast-growing pharmaceutical company headquartered in Dublin, Ireland. Not only does the company have an extensive pipeline of product candidates being developed ...

Ireland-based Alkermes receives royalties from drug makers including Johnson & Johnson for schizophrenia drugs Risperdal Consta and Invega Sustenna and from Amylin Pharmaceutical Inc for diabetes ...